BioCentury
ARTICLE | Company News

Ironwood shareholders vote to keep board intact

June 1, 2018 7:00 PM UTC

Ironwood Pharmaceuticals Inc. (NASDAQ:IRWD) said its shareholders re-elected all three of its preferred board director nominees during its annual shareholder meeting. Alex Denner, who holds about a 2.2% stake in Ironwood and is chief investment officer at activist firm Sarissa Capital Management LP, had been angling for a seat.

The company announced this month it will divide its pipeline of soluble guanylate cyclase (sGC) candidates and its gastrointestinal (GI) business, including marketed products, into two publicly traded companies in a deal expected to close in 1H19...